Abstract
Investigate the extent of discontinuation of oral adjuvant endocrine therapy (OAET) in women nearly 4 years from the diagnosis of their first episode of invasive breast cancer and the reasons for such discontinuation
Original language | English |
---|---|
Pages (from-to) | 15 - 21 |
Number of pages | 7 |
Journal | Menopause |
Volume | 20 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2013 |